14 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
remedy available to it at law or in equity, subject to the terms and conditions of this Agreement.
15.2. Any dispute, controversy or claim that arises
20-F
2021 FY
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
jurisdiction to hear, settle and/or determine any dispute, controversy or claim arising under the provisions of the Securities Act or the Exchange Act … to hear, settle and/or determine any dispute, controversy or claim whether arising out of or in connection with our articles of association or otherwise
424B4
CNTB
Connect Biopharma Holdings Ltd
19 Mar 21
Prospectus supplement with pricing info
4:49pm
jurisdiction to hear, settle and/or determine any dispute, controversy or claim arising under the provisions of the Securities Act or the Exchange Act … to hear, settle and/or determine any dispute, controversy or claim whether arising out of or in connection with our articles of association
F-1/A
CNTB
Connect Biopharma Holdings Ltd
18 Mar 21
Registration statement (foreign) (amended)
6:15am
dispute, controversy or claim arising under the provisions of the Securities Act or the Exchange Act, which are referred to as the “U.S. Actions … , controversy or claim whether arising out of or in connection with our articles of association or otherwise, including without limitation:
any derivative
F-1/A
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
exclusive jurisdiction to hear, settle and/or determine any dispute, controversy or claim arising under the provisions of the Securities Act … jurisdiction to hear, settle and/or determine any dispute, controversy or claim whether arising out of or in connection with our articles of association
F-1/A
EX-10.2
cj2a1
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.11
ck6ys
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
itqxp1ew9wir
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-4.4
xfh41yneb64ug
26 Feb 21
Registration statement (foreign)
4:56pm
F-1
EX-10.5
fhcbmje0
26 Feb 21
Registration statement (foreign)
4:56pm
DRS/A
EX-10.5
jnta izvxs
26 Jan 21
Draft registration statement (amended)
12:00am
DRS/A
eslm7wujvt f9t8g
26 Jan 21
Draft registration statement (amended)
12:00am
DRS
qdba2kftj
17 Dec 20
Draft registration statement
12:00am
DRS
EX-4.4
oy2mysma3j3swdrxjb
17 Dec 20
Draft registration statement
12:00am
- Prev
- 1
- Next